MeVis Medical Solutions AG (ETR:M3V)
Germany · Delayed Price · Currency is EUR 23.20
-0.20 (-0.85%)
May 29, 2026, 5:35 PM CET
ETR:M3V Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 14.95 | 16.06 | 16.97 | 17.34 | 18.76 | 16.21 | |
Revenue Growth (YoY) | -16.36% | -5.36% | -2.14% | -7.57% | 15.71% | -5.35% |
Cost of Revenue | 12.35 | 11.18 | 10.54 | 10.34 | 10.17 | 9.29 |
Gross Profit | 2.6 | 4.88 | 6.43 | 7 | 8.59 | 6.92 |
Selling, General & Admin | 0.55 | 0.55 | 0.55 | 0.56 | 0.56 | 0.47 |
Other Operating Expenses | 1.28 | 1.87 | 1.75 | 1.48 | 1.48 | 1.31 |
Operating Expenses | 1.97 | 2.56 | 2.43 | 2.14 | 2.13 | 1.91 |
Operating Income | 0.63 | 2.32 | 4 | 4.86 | 6.47 | 5.02 |
Interest Expense | -0 | -0 | -0.02 | -0 | - | - |
Interest & Investment Income | 0.04 | 0.09 | 0.15 | 0.11 | - | 0.16 |
Earnings From Equity Investments | - | - | - | - | 0.18 | - |
Currency Exchange Gain (Loss) | -0.21 | -0.21 | -0.5 | -1.01 | 1.23 | 0.06 |
Other Non Operating Income (Expenses) | 0.99 | 1.05 | 1.05 | 1.07 | - | - |
EBT Excluding Unusual Items | 1.46 | 3.26 | 4.69 | 5.03 | 7.88 | 5.24 |
Legal Settlements | - | - | - | - | - | -0.61 |
Other Unusual Items | 0.02 | 0.02 | - | - | - | - |
Pretax Income | 1.48 | 3.28 | 4.69 | 5.03 | 7.88 | 4.63 |
Income Tax Expense | 0.1 | 0.11 | 0.13 | 0.11 | 0.09 | 0.09 |
Net Income | 1.38 | 3.17 | 4.56 | 4.92 | 7.79 | 4.55 |
Net Income to Common | 1.38 | 3.17 | 4.56 | 4.92 | 7.79 | 4.55 |
Net Income Growth | -67.83% | -30.58% | -7.29% | -36.84% | 71.35% | -20.31% |
Shares Outstanding (Basic) | - | 2 | 2 | 2 | 2 | 2 |
Shares Outstanding (Diluted) | - | 2 | 2 | 2 | 2 | 2 |
EPS (Basic) | - | 1.74 | 2.51 | 2.70 | 4.28 | 2.50 |
EPS (Diluted) | - | 1.74 | 2.51 | 2.70 | 4.28 | 2.50 |
EPS Growth | - | -30.58% | -7.29% | -36.84% | 71.35% | -20.31% |
Free Cash Flow | - | 3.74 | 2.84 | 5.77 | 4.72 | 9.08 |
Free Cash Flow Per Share | - | 2.05 | 1.56 | 3.17 | 2.60 | 4.99 |
Dividend Per Share | 1.130 | 1.130 | 1.130 | 0.950 | - | - |
Dividend Growth | - | - | 18.95% | - | - | - |
Gross Margin | 17.38% | 30.38% | 37.91% | 40.38% | 45.80% | 42.70% |
Operating Margin | 4.19% | 14.44% | 23.58% | 28.05% | 34.46% | 30.94% |
Profit Margin | 9.26% | 19.71% | 26.87% | 28.37% | 41.52% | 28.04% |
Free Cash Flow Margin | - | 23.28% | 16.76% | 33.30% | 25.18% | 56.00% |
EBITDA | 0.78 | 2.47 | 4.13 | 4.96 | 6.56 | 5.14 |
EBITDA Margin | 5.22% | 15.36% | 24.36% | 28.60% | 34.96% | 31.71% |
D&A For EBITDA | 0.15 | 0.15 | 0.13 | 0.1 | 0.09 | 0.13 |
EBIT | 0.63 | 2.32 | 4 | 4.86 | 6.47 | 5.02 |
EBIT Margin | 4.19% | 14.44% | 23.58% | 28.05% | 34.46% | 30.94% |
Effective Tax Rate | 6.43% | 3.45% | 2.70% | 2.27% | 1.11% | 1.84% |